跳至主要内容
临床试验/NCT02592694
NCT02592694Unknown4 期

Intracoronary Cocktail Injection Combined With Thrombus Aspiration in ST-elevation Myocardial Infarction Patients Treated With Primary Angioplasty

Xijing Hospital1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2015年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
1,000
试验地点
1
主要终点
Death, Mayocardial infarction, NYHA Ⅳ heart failure

研究概览

简要总结

This is a randomized, double blind, placebo controlled study of intracoronary cocktail injection combined with thrombus aspiration versus thrombus aspiration alone in ST-elevation myocardial infarction patients treated with primary angioplasty.

详细描述

This is a randomized, double blind, placebo controlled study of intracoronary cocktail injection combined with thrombus aspiration versus thrombus aspiration alone in ST-elevation myocardial infarction patients treated with primary angioplasty. Patients with STEMI will be randomized into the cocktail group or the control group. Patients in the cocktail group will receive cocktail injection combined with thrombus aspiration. Patients in the control group will receive thrombus aspiration alone. The primary outcome of the cocktail I study is the composite of death, myocardial infarction or class IV heart failure within 1 year. The secondary outcome of the cocktail I study include slow reflow/no reflow during PCI, left ventricular function, quality of life, stroke or life-threatening bleeding within 1 year.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18-80 years of age adult patients with STEMI Referred for primary PCI within 5d of symptom onset

排除标准

  • Patients who had undergone previous coronary artery bypass surgery or PCI or had received fibrinolytic therapy History of stroke Active bleeding Severe hepatic or renal dysfunction Cardiogenic shock Contraindications for primary PCI or DAPT

研究组 & 干预措施

Cocktail with thrombus aspiration

Experimental

Intracoronary cocktail (tirofiban, bivalirudin, tenecteplase) injection combined with thrombus aspiration

干预措施: cocktail (Drug)

Cocktail with thrombus aspiration

Experimental

Intracoronary cocktail (tirofiban, bivalirudin, tenecteplase) injection combined with thrombus aspiration

干预措施: thrombus aspiration (Device)

Thrombus aspiration

Active Comparator

Thrombus aspiration alone

干预措施: thrombus aspiration (Device)

结局指标

主要结局

Death, Mayocardial infarction, NYHA Ⅳ heart failure

时间窗: 1 year

number of participants with death, mayocardial infarction or NYHA Ⅳ heart failure

次要结局

  • Left ventricular function(1 year)
  • Canadian Cardiovascular Society (CCS) Functional Angina classification(1 year)
  • Seattle Angina Questionnaire scores(1 year)
  • 6-minute walk distance (6MWD)(1 year)
  • Stroke(1 year)
  • Slow reflow/no reflow(intraoperative)

研究者

发起方
Xijing Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

sunddong

Principal Investigator

Xijing Hospital

研究点 (1)

Loading locations...

相似试验